TMC6
Basic information
Region (hg38): 17:78107397-78132407
Previous symbols: [ "EVER1", "TNRC6C-AS1" ]
Links
Phenotypes
GenCC
Source:
- epidermodysplasia verruciformis (Strong), mode of inheritance: AR
- epidermodysplasia verruciformis, susceptibility to, 1 (Strong), mode of inheritance: AR
- epidermodysplasia verruciformis (Supportive), mode of inheritance: AR
- epidermodysplasia verruciformis, susceptibility to, 1 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epidermodysplasia verruciformis, susceptibility to, 1 | AR | Oncologic | Individuals are at high-risk of developing skin cancers, and surveillance may be beneficial to allow early detection and treatment | Allergy/Immunology/Infectious; Dermatologic; Oncologic | 10084299; 10844558; 12426567 |
ClinVar
This is a list of variants' phenotypes submitted to
- Epidermodysplasia verruciformis (24 variants)
- Epidermodysplasia verruciformis, susceptibility to, 1 (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMC6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 162 | 171 | ||||
missense | 292 | 12 | 10 | 314 | ||
nonsense | 10 | |||||
start loss | 1 | |||||
frameshift | 11 | 12 | ||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 17 | 38 | 7 | 62 | ||
non coding | 44 | 135 | 54 | 236 | ||
Total | 24 | 5 | 346 | 309 | 72 |
Highest pathogenic variant AF is 0.0000197
Variants in TMC6
This is a list of pathogenic ClinVar variants found in the TMC6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-78112904-C-T | Likely benign (Jul 09, 2018) | |||
17-78112992-C-T | Benign (Jul 09, 2018) | |||
17-78113152-G-A | Uncertain significance (Jul 01, 2024) | |||
17-78113158-TG-T | Epidermodysplasia verruciformis, susceptibility to, 1 | Uncertain significance (Nov 01, 2018) | ||
17-78113176-G-A | Epidermodysplasia verruciformis | Uncertain significance (Aug 10, 2023) | ||
17-78113179-G-A | Epidermodysplasia verruciformis | Uncertain significance (May 26, 2020) | ||
17-78113182-G-A | Epidermodysplasia verruciformis • Epidermodysplasia verruciformis, susceptibility to, 1 | Conflicting classifications of pathogenicity (Dec 22, 2023) | ||
17-78113183-G-A | Epidermodysplasia verruciformis | Uncertain significance (Dec 31, 2021) | ||
17-78113186-C-G | Epidermodysplasia verruciformis • Inborn genetic diseases | Uncertain significance (Aug 09, 2022) | ||
17-78113186-C-T | Epidermodysplasia verruciformis | Uncertain significance (Jul 25, 2022) | ||
17-78113188-G-A | Epidermodysplasia verruciformis | Uncertain significance (May 27, 2022) | ||
17-78113198-C-T | Epidermodysplasia verruciformis | Uncertain significance (Aug 23, 2022) | ||
17-78113199-G-A | Epidermodysplasia verruciformis | Likely benign (May 12, 2022) | ||
17-78113203-G-A | Inborn genetic diseases | Uncertain significance (Aug 05, 2024) | ||
17-78113205-C-T | Epidermodysplasia verruciformis | Likely benign (Jan 06, 2022) | ||
17-78113207-C-T | Epidermodysplasia verruciformis | Likely benign (May 29, 2023) | ||
17-78113210-C-T | Inborn genetic diseases | Uncertain significance (May 24, 2023) | ||
17-78113211-C-G | Epidermodysplasia verruciformis | Uncertain significance (Dec 07, 2021) | ||
17-78113212-C-G | Epidermodysplasia verruciformis | Uncertain significance (Jul 07, 2020) | ||
17-78113215-C-T | Epidermodysplasia verruciformis • TMC6-related disorder | Benign (Jan 31, 2024) | ||
17-78113218-G-A | Epidermodysplasia verruciformis | Likely benign (Oct 27, 2022) | ||
17-78113219-A-G | Epidermodysplasia verruciformis | Likely benign (Dec 11, 2023) | ||
17-78113220-A-G | Epidermodysplasia verruciformis | Likely benign (Nov 27, 2023) | ||
17-78113231-C-T | Epidermodysplasia verruciformis | Likely benign (Sep 27, 2023) | ||
17-78113277-G-A | not specified | Benign (Jan 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMC6 | protein_coding | protein_coding | ENST00000590602 | 19 | 21950 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.86e-10 | 0.998 | 125699 | 0 | 44 | 125743 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.231 | 481 | 495 | 0.971 | 0.0000335 | 5081 |
Missense in Polyphen | 136 | 144.92 | 0.93842 | 1612 | ||
Synonymous | -0.892 | 252 | 235 | 1.07 | 0.0000167 | 1702 |
Loss of Function | 2.83 | 22 | 41.7 | 0.527 | 0.00000199 | 434 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000698 | 0.000544 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000209 | 0.000193 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000165 | 0.000163 |
Other | 0.000330 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Probable ion channel. {ECO:0000250}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.751
- rvis_EVS
- 0.5
- rvis_percentile_EVS
- 79.66
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- N
- hipred_score
- 0.198
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.154
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Tmc6
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- biological_process;ion transmembrane transport;neutrophil degranulation
- Cellular component
- cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;integral component of plasma membrane;nuclear membrane;specific granule membrane;extracellular exosome;tertiary granule membrane
- Molecular function
- ion channel activity;protein binding;mechanosensitive ion channel activity